Latest Analysis

1,845 tickers · updated regularly
Ranks this page's recent reports by score.
RLX Technology Inc.
RLX·Consumer Staples
B ★★★Hold
Current$1.81
Target$2.50
Return+38.1%
Aug 24, 2026

Backed by a $2.04 billion cash fortress that effectively prices the core business at zero, RLX offers immense deep-value optionality via its European expansion, provided it can successfully navigate the structural margin dilution and persistent global regulatory hostility.

Score
82
BJ's Wholesale Club Holdings, Inc.
BJ·Consumer Staples
A ★★★★Buy
Current$96.42
Target$115.00
Return+19.3%
Aug 24, 2026

BJ's is a highly profitable, cash-gushing warehouse club trading at an unjustifiable discount to its peers, though investors must monitor whether its aggressive expansion into Costco-dominated territories can maintain the high margins recently subsidized by a volatile fuel environment.

Score
91
Ubiquiti Inc.
UI·Technology
C ★★Sell
Current$557.14
Aug 24, 2026

Ubiquiti boasts unparalleled capital efficiency and a fiercely loyal, license-free networking ecosystem, but extreme overvaluation, total disenfranchisement of minority shareholders, and explosive litigation risks regarding military technology smuggling mandate an immediate exit.

Score
66
Supernus Pharmaceuticals, Inc.
SUPN·Healthcare
A ★★★★Buy
Current$45.85
Target$63.00
Return+37.4%
Aug 24, 2026

Supernus is rapidly transforming from a legacy epilepsy drugmaker into a $2.2 billion diversified CNS powerhouse trading at a severely discounted valuation, though investors must remain hyper-vigilant regarding the profound, complex execution risks inherent in integrating the massive Indivior mega-merger.

Score
85
Structure Therapeutics Inc.
GPCR·Healthcare
B ★★★Hold
Current$49.09
Target$104.77
Return+113.4%
Aug 24, 2026

Structure Therapeutics is advancing a highly potent, infinitely scalable oral GLP-1 and amylin pipeline that rivals injectables in clinical efficacy, though near-term price volatility and intense big-pharma competition warrant a highly disciplined, milestone-driven accumulation strategy.

Score
76
AvePoint, Inc.
AVPT·Technology
A ★★★★Buy
Current$13.37
Target$17.00
Return+27.1%
Aug 24, 2026

AvePoint is a highly profitable, Rule of 40 cloud data management platform dominating the Microsoft ecosystem, offering a compelling compounding opportunity despite risks tied to ecosystem dependence and recent insider selling.

Score
86
Centuri Holdings, Inc.
CTRI·Utilities
B ★★★Hold
Current$21.36
Target$28.20
Return+32.0%
Aug 24, 2026

Centuri is a deeply entrenched, highly visible tollbooth for North America's multi-decade grid modernization and data center buildout, offering profound intrinsic undervaluation, though investors must endure near-term margin volatility tied to aggressive capacity expansion and input inflation.

Score
75
Harley-Davidson, Inc.
HOG·Consumer Discretionary
B ★★★Hold
Current$28.20
Target$31.35
Return+11.2%
Aug 24, 2026

Harley-Davidson offers a deeply discounted, cash-rich turnaround play backed by massive insider conviction and aggressive buybacks, though investors must remain acutely wary of the permanent margin damage threatened by the brand's inevitable pivot toward lower-priced, entry-level motorcycles in a demographically shrinking market.

Score
77
Adeia Inc.
ADEA·Technology
S ★★★★★Strong Buy
Current$26.25
Target$37.03
Return+41.1%
Aug 24, 2026

Adeia leverages an expansive media and semiconductor patent portfolio to generate massive, high-margin cash flows, offering an asymmetric compounding profile as hybrid bonding adoption accelerates across AI infrastructure, despite the secular headwinds facing its legacy pay-TV licensing segment.

Score
98
Ardagh Metal Packaging S.A.
AMBP·Consumer Discretionary
B ★★★Hold
Current$5.36
Target$6.17
Return+15.1%
Aug 24, 2026

Ardagh Metal Packaging offers a massive 7.46% dividend yield and deep free-cash-flow value driven by specialty can adoption, but investors must remain highly vigilant regarding its 5.2x leverage profile and the looming secondary supply risk of its parent company's 76% ownership block sale.

Score
82
DHT Holdings, Inc.
DHT·Energy
A ★★★★Buy
Current$19.82
Target$31.02
Return+56.5%
Aug 24, 2026

DHT is a highly disciplined, cash-gushing tollbooth capitalizing on historically tight crude supply chains, though investors must remain hyper-vigilant regarding the sudden evaporation of geopolitical risk premiums that currently inflate spot rates.

Score
94
First Merchants Corporation
FRME·Financials
B ★★★Hold
Current$42.03
Target$50.00
Return+19.0%
Aug 24, 2026

First Merchants offers an optically cheap, high-yield dividend stream fortified by structural net interest margin expansion, but investors must exercise near-term caution until the true depth of recent commercial credit defaults is proven to be fully ring-fenced.

Score
84
DENTSPLY SIRONA Inc.
XRAY·Healthcare
B ★★★Hold
Current$10.92
Target$15.50
Return+41.9%
Aug 24, 2026

Priced as a terminal business, Dentsply Sirona offers massive asymmetric upside backed by surging free cash flow and aggressive share repurchases, though investors must navigate the white-knuckle risks of a highly leveraged balance sheet and deteriorating end-market demand.

Score
76
Benchmark Electronics, Inc.
BHE·Technology
C ★★Sell
Current$73.36
Aug 24, 2026

Benchmark is flawlessly executing a high-margin pivot driven by AI and semiconductor manufacturing megatrends, but its stock has expanded to a dangerously overvalued multiple that completely ignores the extreme cyclicality inherent to the contract electronics industry.

Score
65
Sunrun Inc.
RUN·Technology
B ★★★Hold
Current$9.16
Target$12.60
Return+37.6%
Aug 23, 2026

Sunrun possesses unprecedented, asymmetrical upside as the primary architect of America's dispatchable VPP infrastructure, yet it remains a highly volatile near-term asset demanding extreme patience due to skyrocketing customer creation costs, heavy debt reliance, and severe execution risks amid its sales channel transition.

Score
76
Beam Therapeutics Inc.
BEAM·Healthcare
A ★★★★Buy
Current$29.76
Target$47.63
Return+60.0%
Aug 23, 2026

Beam Therapeutics is the undisputed pioneer of base editing, trading at a discount despite a fortified balance sheet, though investors must navigate the execution risks of commercializing complex ex-vivo therapies.

Score
86
WaFd, Inc.
WAFD·Financials
B ★★★Hold
Current$36.38
Target$38.50
Return+5.8%
Aug 23, 2026

WaFd offers an attractive dividend and strong commercial loan growth, but relentless deposit competition and compressed net interest margins cap near-term valuation upside, warranting a Hold.

Score
76
National Energy Services Reunited Corp.
NESR·Energy
A ★★★★Buy
Current$33.03
Target$43.04
Return+30.3%
Aug 23, 2026

Riding an unprecedented sovereign upstream supercycle in the MENA region, NESR combines explosive, contracted EPS growth with a pristine new capital return program, though investors must tolerate extreme customer concentration and perpetual geopolitical volatility.

Score
85
Versigent PLC
VGNT·Consumer Discretionary
A ★★★★Buy
Current$49.26
Target$73.60
Return+49.4%
Aug 23, 2026

Versigent is a deeply entrenched, cash-gushing tollbooth for global vehicle electrification trading at a drastically misunderstood distressed valuation, though investors must stomach the inevitable quarter-to-quarter volatility driven by copper prices and cyclical global auto production.

Score
94
BKV Corporation
BKV·Energy
B ★★★Hold
Current$24.20
Target$32.50
Return+34.3%
Aug 23, 2026

BKV is pioneering a highly profitable, integrated 'molecules to megawatts' strategy perfectly positioned for the AI data center boom, though near-term upside is constrained by uncontracted capital expenditure risks and persistent insider selling.

Score
80
Medical Properties Trust, Inc.
MPT·Real Estate
B ★★★Hold
Current$4.12
Target$5.70
Return+38.3%
Aug 23, 2026

Medical Properties Trust offers an extreme deep-value turnaround opportunity after successfully navigating a near-fatal tenant bankruptcy and debt wall, though investors must tolerate massive volatility and execution risk as interim operators attempt to stabilize cash flows.

Score
77
The Bancorp, Inc.
TBBK·Financials
S ★★★★★Strong Buy
Current$67.19
Target$86.00
Return+28.0%
Aug 23, 2026

The Bancorp leverages its dominant, highly profitable tollbooth position in the fintech ecosystem to fund an aggressive share-cannibalization strategy at a deep valuation discount, though investors must remain hyper-vigilant regarding intense federal regulatory scrutiny of the Banking-as-a-Service sector.

Score
97
InvenTrust Properties Corp.
IVT·Real Estate
B ★★★Hold
Current$32.69
Target$34.92
Return+6.8%
Aug 23, 2026

InvenTrust operates a fiercely defensive, low-leverage tollbooth on Sun Belt demographic growth via grocery-anchored retail, though investors must recognize that the stock's elevated peer premium currently restricts asymmetric upside.

Score
79
Wix.com Ltd.
WIX·Technology
B ★★★Hold
Current$82.07
Target$113.04
Return+37.7%
Aug 23, 2026

Wix offers deep value driven by extreme free cash flow generation and the aggressive retirement of 30% of its float, though investors must tolerate severe near-term margin volatility and legal overhangs tied to its costly AI transition.

Score
83